Younes, A., Oki, Y., Bociek, R. G., Kuruvilla, J., Fanale, M., Neelapu, S., . . . Martell, R. E. (2011). Phase II Study of Mocetinostat (MGCD0103) In Patients with Relapsed and Refractory Classical Hodgkin Lymphoma. Lancet Oncol.
Style de citation ChicagoYounes, Anas, et al. "Phase II Study of Mocetinostat (MGCD0103) In Patients With Relapsed and Refractory Classical Hodgkin Lymphoma." Lancet Oncol 2011.
Style de citation MLAYounes, Anas, et al. "Phase II Study of Mocetinostat (MGCD0103) In Patients With Relapsed and Refractory Classical Hodgkin Lymphoma." Lancet Oncol 2011.
Attention : ces citations peuvent ne pas être correctes à 100%.